Oncotelic Therapeutics Inc (OTLC)
0.0394
0.00 (0.00%)
USD |
OTCM |
May 03, 16:00
Oncotelic Therapeutics Price to Book Value: 1.298 for May 3, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 03, 2024 | 1.298 |
| May 02, 2024 | 1.263 |
| May 01, 2024 | 1.278 |
| April 30, 2024 | 1.316 |
| April 29, 2024 | 1.384 |
| April 26, 2024 | 1.384 |
| April 25, 2024 | 1.344 |
| April 24, 2024 | 1.252 |
| April 23, 2024 | 1.186 |
| April 22, 2024 | 1.298 |
| April 19, 2024 | 1.298 |
| April 18, 2024 | 1.384 |
| April 17, 2024 | 1.348 |
| April 16, 2024 | 1.354 |
| April 15, 2024 | 1.354 |
| April 12, 2024 | 1.351 |
| April 11, 2024 | 1.351 |
| April 10, 2024 | 1.349 |
| April 09, 2024 | 1.367 |
| April 08, 2024 | 1.382 |
| April 05, 2024 | 1.349 |
| April 04, 2024 | 1.222 |
| April 03, 2024 | 1.169 |
| April 02, 2024 | 1.161 |
| April 01, 2024 | 1.280 |
| Date | Value |
|---|---|
| March 28, 2024 | 1.184 |
| March 27, 2024 | 1.185 |
| March 26, 2024 | 1.300 |
| March 25, 2024 | 1.206 |
| March 22, 2024 | 1.206 |
| March 21, 2024 | 1.231 |
| March 20, 2024 | 1.224 |
| March 19, 2024 | 1.193 |
| March 18, 2024 | 1.152 |
| March 15, 2024 | 1.221 |
| March 14, 2024 | 1.382 |
| March 13, 2024 | 1.250 |
| March 12, 2024 | 1.382 |
| March 11, 2024 | 1.382 |
| March 08, 2024 | 1.382 |
| March 07, 2024 | 1.245 |
| March 06, 2024 | 1.239 |
| March 05, 2024 | 1.316 |
| March 04, 2024 | 1.316 |
| March 01, 2024 | 1.198 |
| February 29, 2024 | 1.161 |
| February 28, 2024 | 1.237 |
| February 27, 2024 | 1.239 |
| February 26, 2024 | 1.241 |
| February 23, 2024 | 1.315 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
0.4017
Minimum
Jun 27 2023
14.29
Maximum
Apr 05 2022
3.444
Average
1.308
Median
Price to Book Value Benchmarks
| Mosaic ImmunoEngineering Inc | -- |
| NovaBay Pharmaceuticals Inc | 2.094 |
| Palatin Technologies Inc | -- |
| iBio Inc | 0.7539 |
| Theriva Biologics Inc | 0.187 |
Price to Book Value Related Metrics
| Price | 0.0394 |
| Earnings Yield | -53.42% |
| Market Cap | 15.75M |